Hazlett Burt & Watson Inc. boosted its position in Veralto Co. (NYSE:VLTO – Free Report) by 550.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,185 shares of the company’s stock after purchasing an additional 1,849 shares during the quarter. Hazlett Burt & Watson Inc.’s holdings in Veralto were worth $244,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also bought and sold shares of the company. Goodman Advisory Group LLC bought a new position in shares of Veralto in the 2nd quarter worth $26,000. LRI Investments LLC bought a new position in shares of Veralto in the 1st quarter worth $30,000. Fairscale Capital LLC bought a new position in shares of Veralto in the 2nd quarter worth $30,000. Raleigh Capital Management Inc. grew its holdings in shares of Veralto by 692.3% during the 3rd quarter. Raleigh Capital Management Inc. now owns 309 shares of the company’s stock valued at $35,000 after purchasing an additional 270 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new position in shares of Veralto during the 2nd quarter valued at $43,000. 91.28% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Veralto
In other Veralto news, SVP Surekha Trivedi sold 7,399 shares of Veralto stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $110.00, for a total transaction of $813,890.00. Following the transaction, the senior vice president now owns 12,671 shares of the company’s stock, valued at $1,393,810. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Jennifer Honeycutt sold 13,190 shares of the business’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $110.15, for a total value of $1,452,878.50. Following the transaction, the chief executive officer now owns 138,546 shares of the company’s stock, valued at approximately $15,260,841.90. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Surekha Trivedi sold 7,399 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $110.00, for a total transaction of $813,890.00. Following the completion of the transaction, the senior vice president now directly owns 12,671 shares in the company, valued at $1,393,810. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 36,038 shares of company stock valued at $3,989,693 over the last 90 days. 0.31% of the stock is currently owned by corporate insiders.
Veralto Stock Performance
Veralto (NYSE:VLTO – Get Free Report) last announced its earnings results on Wednesday, October 23rd. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.04. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.30 billion. Veralto had a net margin of 15.69% and a return on equity of 52.85%. The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.75 earnings per share. On average, research analysts anticipate that Veralto Co. will post 3.48 earnings per share for the current year.
Veralto Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Friday, September 27th were given a dividend of $0.09 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.36 annualized dividend and a yield of 0.35%. Veralto’s dividend payout ratio (DPR) is 11.11%.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on VLTO shares. The Goldman Sachs Group increased their target price on shares of Veralto from $104.00 to $116.00 and gave the company a “buy” rating in a report on Monday, July 29th. Stifel Nicolaus raised their target price on shares of Veralto from $117.00 to $119.00 and gave the stock a “buy” rating in a research report on Wednesday, October 16th. TD Cowen lifted their price target on shares of Veralto from $95.00 to $100.00 and gave the company a “hold” rating in a research report on Tuesday, July 30th. UBS Group began coverage on shares of Veralto in a research report on Tuesday, August 13th. They set a “neutral” rating and a $118.00 price target for the company. Finally, BMO Capital Markets raised their price objective on shares of Veralto from $117.00 to $119.00 and gave the company an “outperform” rating in a research note on Monday, September 30th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Veralto currently has an average rating of “Hold” and a consensus target price of $108.27.
Read Our Latest Analysis on Veralto
Veralto Profile
Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.
See Also
- Five stocks we like better than Veralto
- How to Choose Top Rated Stocks
- Intel: Is Now the Time to Be Brave?Â
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding VLTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veralto Co. (NYSE:VLTO – Free Report).
Receive News & Ratings for Veralto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veralto and related companies with MarketBeat.com's FREE daily email newsletter.